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Ataxia Telangiectasia (AT) patients are particularly sensitive to oxidative–nitrosative stress. Nitric oxide (NO) controls mitochondrial
respiration via the reversible inhibition of complex IV. The mitochondrial response to NO of AT lymphoblastoid cells was investigated. Cells
isolated from three patients and three intrafamilial healthy controls were selected showing within each group a normal diploid karyotype and
homogeneous telomere length. Different complex IV NO-inhibition patterns were induced by varying the electron flux through the respiratory
chain, using exogenous cell membrane permeable electron donors. Under conditions of high electron flux the mitochondrial NO inhibition of
respiration was greater in AT than in control cells (P≤0.05). This property appears peculiar to AT, and correlates well to the higher concentration
of cytochrome c detected in the AT cells. This finding is discussed on the basis of the proposed mechanism of reaction of NO with complex IV. It
is suggested that the peculiar response of AT mitochondria to NO stress may be relevant to the mitochondrial metabolism of AT patients.
© 2007 Elsevier B.V. All rights reserved.Keywords: Nitrosative stress; Bioenergetics; Cytochrome c oxidase; Genetic disease; Reaction mechanism; Respiratory chain1. Introduction
AT is an autosomal recessive multisystemic disorder char-
acterised by conjunctival telangiectasia and by degeneration of
the cerebellar Purkinje and granule neurons, leading to
progressive ataxia [1,2]. The disease is caused by mutations
of the AT-Mutated gene (ATM), encoding for a nuclear 350 kDa
protein [3]. The ATM protein plays a fundamental role in
controlling cell cycle and in responding to DNA damage [4,5].
AT patients as well as ATM-deficient mice are characterised by
a high degree of genetic instability and susceptibility to
spontaneous and ionising radiation-induced oxidative stress,
with high levels of oxidative DNA damage [6–10]. Compared
to wt cells, AT cells are characterised by a defective reactive⁎ Corresponding author. Dipartimento di Scienze Biochimiche “A. Rossi
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doi:10.1016/j.bbabio.2007.10.016oxygen species (ROS) scavenging capacity [11,12]. The
intracellular concentration of reduced glutathione is decreased
in AT cells [12], and the dietary supplementation of the anti-
oxidant and NO scavenger N-acetyl cysteine to ATM-deficient
mice improves their genetic stability and off-spring fitness [7].
ROS as well as reactive nitrogen species (RNS), and partic-
ularly NO and the superoxide ion O2
– play important roles in cell
signalling and pathophysiology [13–15]. Bioavailability of ROS
and RNS depends on their relative rate of production and
degradation/scavenging [16] as well as on the reciprocal O2
– and
NO self-quenching rate; these species almost instantaneously
react to form peroxynitrite ONOO–, another highly reactive com-
pound [17,18]. At sub-micromolar concentrations, NO displays a
variety of physiological actions [19–21], including the rapid and
reversible inhibition of mitochondrial respiration [22–25].
Cytochrome c oxidase (CcOX), i.e. mitochondrial complex
IV, has been identified as the primary fast-reacting (milliseconds)
and high affinity target for NO (Kd≈nM) [24, and references
therein cited], although other mitochondrial complexes also react
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hours [26]. The reaction of NO with CcOX is responsible for the
fast inhibition of respiration that occurs with the addition of NO to
respiring systems in vitro [22–24]. This reaction has been shown
to follow two different pathways [24,27], leading to formation of
either a nitrite- (CcOX–NO2
–) or a nitrosyl-derivative (CcOX–
NO) of CcOX [28]. The rate of electron flow through the
respiratory chain, particularly at the cytochrome c/cytochrome c
oxidase site is crucial to the formation of the two derivatives
[28,29]. CcOX–NO is formed in competition with O2 and
predominates at high electron fluxes through the respiratory chain
[24]. Both nitrite- and the nitrosyl-adducts are reversibly inhibited
and regenerate fully active CcOX, although with markedly
different kinetics. CcOX–NO2
– recovers function more rapidly
than CcOX–NO and its formation is not competitive with O2
[24,30]. CcOX–NO is more stable in the dark (as in our body)
than in light [28,29,31] and in its presence the respiratory chain
remains inhibited for longer times than in the presence of CcOX–
NO2
– [28,29]. Last but not least, CcOX–NO releases NO since the
nitrosylated mitochondrial enzyme is unable to further oxidise or
reduce NO, at least in vitro [24,32].
In this paper we report that mitochondrial respiration of
peripheral lymphoblastoid (Epstein–Barr virus transformed)
cells from AT patients, in the presence of atmospheric O2,
micromolar NO (0.5–2 μM) and cell permeable reductants,
remains inhibited for longer times than wt cells. The results
suggest that under conditions favouring electron transfer to
cytochrome c oxidase and in the presence of NO, CcOX–NO is
accumulated in AT cells significantly more than in wt cells.
2. Materials and methods
2.1. Cell culture
Lymphoblastoid cells were isolated and stabilized from 3 Ataxia Telangiec-
tasia patients genetically characterised by RT-PCR, and showing in-frame
deletions or premature truncation throughout the ATM gene, fully supporting the
classical AT phenotype [33,34]. Cells were grown (incubator) at 37 °C and 5%
CO2 in RPMI 1640, 15% foetal calf serum, containing 100 IU–100 μg/ml
penicillin–streptomycin and 2mML-glutamine. All patients and healthy controls
signed an informed consensus, according to the guidelines approved by the
Italian Society of Human Genetics (SIGU), and in full compliance with the
principles enunciated in the Declaration of Helsinki. Three healthy relatives were
selected as controls, sharing with the patients common genetic background. Cell
ploidy was monitored on 200 mitoses for each cell line, to assess putative
cytogenetic differences related to cell aging and time of culture. All measurements
were carried out using cells at comparable growing stages, monitored by analysis
of telomeres carried out using quantitative fluorescence in situ hybridization
(Q-FISH). The integrated fluorescence intensity value proportional to the number
of hybridized probes was calculated for densitometry using the IAS2000 software
(Delta Sistemi, Roma, Italy). The fluorescence shown by AT was slightly (20%)
lower than that of wild type cells, consistently with previous reports [35].
2.2. Reduction of mitochondrial tetramethyl-p-phenylenediamine
(TMPD)
Cells, 1×107 ml–1, were incubated for ∼10 min with 3 mM TMPD, carefully
washed and suspended in dye-free medium. In the absence of exogenous ascorbate
the TMPD reaching mitochondria is oxidised to TMPD+ by cytochrome c oxidase
and O2, and the cell suspension turns to bluish within minutes. To determine
the plasma membrane permeability of ascorbate, TMPD-loaded cells, 0.5×106cells ml–1, were mixed (by hand) under gentle stirring with ascorbate at 25 °C; the
reduction of TMPD was measured spectrophotometrically in the presence of
100 μM cyanide, to avoid TMPD re-oxidation by CcOX. The use of rapid mixing
devices (stopped flow) operating at relatively high pressure (≥2.5 atm) was not
compatible with cell integrity.
Regardless to cell type, oxidised TMPD was found accumulated in the cells,
likely in the mitochondria [36,37] at approximately 1 μM concentration, as
determined spectrophotometrically using the extinction coefficient at 610 nm
ΔE(ox–red)=10 mM
–1 cm–1 independently calculated in PBS, 10 mM glucose and
1 mM CaCl2 (not shown). Cell viability determined after the experiment was
>95%, by trypan blue exclusion. TMPD+ was reduced by ascorbate under
conditions compatible with a bimolecular reaction lasting a few tenths of seconds.
The apparent second order rate constant k was calculated by fitting the





¼ kt Ao−Boð Þ
where Ao and Bo are the initial concentrations of A (ascorbate) and B (TMPD
+)
and x is the amount reacted at time t.
2.3. Immunodetection analysis
AT and wt cell lysates were obtained under rigorously comparable con-
ditions. In the immunoblotting assay, 30 μg proteins were resolved on 12%
SDS-PAGE, transferred to nitrocellulose membranes (Whatman) and incubated
with the primary antibody anti-cytochrome c ((7H8):SC-13560, Santa Cruz)
diluted 1:200, and anti-β-actin ((clone AC15:A-1978) Sigma Chemical Co.),
diluted 1:800, overnight at 4 °C. After incubation with the appropriate species-
specific IgG conjugates, the membranes were exposed to chemiluminescence
reagents (Amersham). Quantification of band intensities was carried out by the
KODAK 1D Image Analysis Software (Eastman Kodak Company, Rochester
NY). The blot shown is representative of three independent experiments of both
AT and wt cells.
In the ELISA assay, 1.5×106 cells were suspended in 1 ml lysis buffer
(ELISA kit Bender Med Systems, Vienna, A) and after a 1:50 dilution in the
same buffer, an aliquot was processed by commercially available enzyme-linked
immunosorbent assay for quantitative detection of human cytochrome c,
according to the manufacturer's instructions. The data shown represent the
average of eight replicates of both AT and wt cells.
2.4. Citrate synthase
The total cell mitochondrial mass was evaluated by measuring the citrate
synthase (CS) activity. Cells were lysed using CelLytic™M Cell-Lysis reagent
from Sigma. Extracts of 106 cells were centrifuged at 20,000 ×g and
supernatants assayed for the total protein content [38] and for citrate synthase
[39]. The citrate synthase activity of AT and wt cells was 0.105±0.0030 and
0.107±0.0084 μmol/min/mg protein, respectively, indicating that the mitochon-
drial mass of these cell lines is very similar.
2.5. Polarographic measurements (O2, NO)
Oxygen and NO (authentic gas solution) consumption was measured
amperometrically in a gas proof vessel containing NO- and O2-sensitive
electrodes, either from WPI (Duo18 or Apollo 4000-Model, World Precision
Instruments, Inc., Sarasota, FL-USA) or from OROBOROS Instruments
(Innsbruck, A) allowing high resolution respirometry; in this case data points
were collected using the built in software DatLab 4, and kinetic flux analysis
performed with DatLab 2 (integration time ≤2 s, and minimizing smoothing).
The NO-inhibition experiment was designed according to [28,29] with minor
modifications to probe the mitochondrial accumulation of the CcOX–NO
adduct. Cells (1×107 ml–1) were allowed to respire at 25 °C in air-equilibrated
medium (∼270 μMO2) as such or in the presence of exogenous ascorbate, up to
30 mM and TMPD, reductants able to maintain cytochrome c (virtually) fully
reduced [29,37]. After stabilization, NO (2 μM, typically) was added to the
reaction chamber and inhibition of respiration occurred immediately, confirming
that the observed O2 consumption was due to CcOX; care was taken to keep the
Fig. 1. Cell respiration. Cells (1×107 ml−1) suspended in PBS, glucose 10 mM
and CaCl2 1 mM were transferred into the polarographic vessel. Excess ascor-
bate, and TMPD were added from concentrated stock solutions to minimize
dilution. Each data point represents the average of independent measurements
carried out on every cell line. Wild type cells (○), Ataxia Telangiectasia cells
(●). T=25 °C. Values represent the mean±SEM (n=6–9). ⁎, Pb0.05 vs wt
cells (details in Materials and methods).
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formed [28,29]. Afterwards, residual free NO was removed with human oxy-
haemoglobin (HbO2 2.0 μM, heme basis) and the time course of respiration
recovery in the absence of free NO followed. Rates of O2 consumption were
measured under stationary conditions before addition of NO (Vb) and compared
to the rate measured 45 s after HbO2 addition (Va), i.e. at a time suitable for
complete removal of NO. The Va/Vb ratio has been taken as indicative of the
fraction of CcOX–NO still existing 45 s after free NO removal, and at 25 °C. The
Va/Vb ratio is proportional to the fraction of active enzyme which is limited by the
mono-exponential thermal dissociation of NO from the enzyme. When a sig-
nificant amount of CcOX–NO is formed, theVa/Vb ratio decreases. As previously
reported [28,29] illumination of the sample with a bright (heat-filtered) white
light (150 W tungsten lamp) removes inhibition. The estimated rate of the NO
dissociation is consistent with koff≈10–2 s–1 (T=25 °C) [28]. In the presence of




Cells (4–8×105 cells/ml) were cultured overnight using an antibiotic-free
RPMI 1640 medium; thereafter, cells were further incubated 4 h in the absence
or presence of 11 mM glucose and 2 mM L-glutamine. When required, 2.5 μg/ml
oligomycin was added to the samples during the last 1.5 h. A 100 μl aliquot of
each sample (5×104 cells, containing similar amounts of total proteins) was used
for the chemiluminometric determination of ATP (ATPlite detection kit, Perkin
Elmer). Measurements of the luminometric signal were carried out with the plate
reader VICTOR™ Multilabel Counter (Perkin Elmer) in white 96 well plates.
2.7. Lactate measurements
Cells (4–8×105 cells/ml) were cultured overnight in antibiotic-free RPMI
medium and then starved for 1 h in PBS free of glucose. After starvation, cells
(1×106 cells/ml) were incubated in PBS containing glucose, 1 mM, and in the
presence or absence of myxothiazol and antimycin A (10 μM each); after 3 h,
cells were treated with HClO4, 80 mM [40]. After centrifugation (800–1000 ×g,
at 4 °C, 10 min), supernatant was collected and the lactate concentration
determined spectrophotometrically. The difference between the basal glycolytic
lactate and the lactate produced in the presence of myxothiazol and antimycin
was defined asΔlactate [41]. TheΔlactate divided by the basal lactate value has
been taken as indicative of the ratio between oxidative phosphorylation
(OXPHOS) and glycolytic ATP.
2.8. Statistics
Data points represent the average of repeats (figure legends) carried out
using different cell lines from patients (n=3) and from healthy controls (n=3).
Significance was determined using the Student t-test, run by Excel (Microsoft
Windows platform). The error bars correspond to the standard error of the mean
(SEM); all P values correspond to 2-sample t-test assuming unequal variances.
2.9. Chemicals
Sodium ascorbate, tetramethyl-p-phenylenediamine (TMPD) and cell cul-
ture mediumwere from Sigma Chemical Co. (St. Louis, MO). Stock solutions of
NO (Air Liquide, Paris, France) were prepared by equilibrating degassed water
with the pure gas at 1 atm and at 20 °C; the NO concentration was [NO]=2.1±
0.1 mM. Concentration of human oxy-haemoglobin (HbO2) is expressed on the
heme basis, (∈555=12.5 mM–1 cm–1 in the deoxygenated state).
3. Results
3.1. Cell respiration
Mitochondrial respiration was evaluated using intact cells
maintained in culture under basal metabolic conditions. Theexperiments were carried out using the cells as such or in the
presence of excess ascorbate and increasing amounts of TMPD,
to directly reduce cytochrome c and thereby CcOX [37]. The
rate of O2 consumption in the absence of exogenous reductants
was VO2≈6±0.5 nmol min
–1 107 cells–1, a value similar for
both AT and wt cells (Fig. 1). Upon addition of exogenous
reductants, respiration increases with TMPD in both cell lines
but to a greater extent (approximately twice as much) in AT than
in wt. The intracellular reduction of oxidised TMPD by
ascorbate was evaluated. Both the amplitude and rate of
TMPD reduction were similar in wt and ATcells, thus excluding
a significant difference in the cell membrane permeability to
ascorbate (Fig. 2). The calculated bimolecular rate constant
values were kb=3.5 and 4.5×10
4 M–1 s–1, in AT and wt
respectively. The rate constant value measured in solution,
kb=8.5×10
4 M–1 s–1 (inset to Fig. 2) was faster by a factor of
two, suggesting that the membrane does exert some degree of
control of ascorbate permeation.
The concentration of cytochrome c was measured by
immunoblot and ELISA. As shown in Fig. 3, the relative
densitometric intensity of the cytochrome c band detected in AT
cells is ∼70% greater than in wt cells. The amount of cyto-
chrome c detected by ELISA was 0.48±0.013 μg and 0.67±
0.012 μg/mg total proteins for wt and AT, respectively, ac-
counting for an increment of ∼40%.
3.2. Cytochrome c oxidase response to NO
Cytochrome c oxidase purified, in mitochondria or in intact
cells, undergoes rapid inhibition by NO, reacting with the
metals in the active site of the enzyme (see Introduction). The
degree of CcOX inhibition depends on the electron flux through
the respiratory chain appearing higher in ATcells; thus, we have
measured the response of AT and control cells to NO. In order to
vary the rate of electron transfer at the cytochrome c/CcOX site,
the cells suspended in air-equilibrated medium were allowed to
respire in the presence of excess ascorbate and increasing
amounts of TMPD. Inhibition of respiration was induced by
Fig. 3. Cytochrome c immunodetection. Panel A: Immunoblot. Cell lysates,
30 μg of protein per well, ctr = cytochrome c control. The relative densitometric
intensity (RDI) value of wild type cells (wt), and Ataxia Telangiectasia cells
(AT) represents the average of 3 independent experiments, ⁎, Pb0.05 vs wild
type cells. Panel B: ELISA. Lysates (3×104 cells/ml) were assayed according to
the manufacturer's instructions (Bender Med Systems, Vienna, A) and values
obtained were expressed as μg cytochrome c per mg of total proteins, deter-
mined according to Bradford [38]. n=8, ⁎⁎, Pb0.01 vs wild type cells.
Fig. 2. Ascorbate reduction of TMPD in solution (△) and in cells, AT (●) and wt (○) Time courses of reduction of TMPD,∼1 μM, by ascorbate, 2 μM. The solid lines
represent the best fit of the experimental data to a second order kinetic equation; Inset: second order rate constant values of reduction of oxidised TMPD by ascorbate.
Values represent the mean±SEM (n=3). T=25 °C.
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respiring cells, and in the dark to stabilize the nitrosyl CcOX–
NO derivative (Fig. 4). It is worth recalling that the detection of
a delay in the recovery of respiration has been shown to be
related to the existence of CcOX–NO [28]. As previously
reported with neuroblastoma cells [29], when respiration of both
wt and AT cells is sustained only by endogenous substrates, no
detectable residual inhibition of cell respiration is observed after
(free) NO exhaustion (not shown). Upon addition of TMPD and
ascorbate, compared to wt, AT cells displayed a substantial
residual inhibition after disappearance of bulk NO even in the
presence of HbO2 used to trap any free NO (putative, and below
the electrode sensitivity). This residual inhibition, observed at
25 °C and in the absence of bulk NO, was abolished by ex-
posing cells to an intense heat-filtered white light, confirming
the existence of the light-sensitive Fe2+NO bond (Fig. 5A) [28].
The percentage of residual inhibition measured 45 s after addi-
tion of HbO2 increases with the concentration of TMPD and is
significantly higher in AT compared to wt cells (Fig. 5A). The
correlation between the inhibition of respiration observed at
the time fixed and the rate of O2 consumption at any TMPD
concentration is reported in Fig. 5B. Regardless of the cell type,
all data points lie on the same curve and extrapolate to the same
limiting value corresponding to approximately ∼40% residual
inhibition, compatible with the previously reported dissociation
kinetics of NO from the CcOX active site [28] (seeMaterials and
methods). This finding suggests that the mechanism of CcOX
inhibition via formation of CcOX–NO and its dependence on
the electron transfer rate, i.e. respiration rate, are similar in all
cell lines investigated. Thus, the different NO inhibition of AT
and control cells is likely related to properties of the respiratory
chain downhill with respect to TMPD, well correlating to the
higher concentration of cytochrome c observed in AT.
3.3. Mitochondria metabolism
The steady state concentration of ATP in AT and wt cells has
been evaluated under standard growing conditions. The overallamount of ATP detectable at steady state in wt and AT cells is
21.0±2.6 and 23.0±2.8 nmol/107 cells, in the presence of
glucose; in its absence, ATP concentrations are 22.0±1.4 and
26.0±2.3 nmol/107 cells, respectively (see Fig. 6A, top). Thus
the absolute concentration of ATP appears only slightly higher
in AT than in wt, and more clearly in the absence of glucose. In
Fig. 4. Inhibition of wild type and AT cells respiration by NO. (Panels A, C) Typical amperometric NO and O2 profiles, recorded in the dark in the presence of excess
ascorbate and TMPD, 1 mM. Vb = rate of O2 consumption before NO addition; Va = rate of O2 consumption after addition of HbO2, i.e. in the absence of free NO (see
lower profiles). In = inhibited state (in the presence of free NO). In order to assess the fraction of residual inhibited CcOX–NO, the instantaneous rate was measured
45 s after HbO2 addition. Under these conditions, AT is inhibited by 32.38±3.8%, whereas wt by 16.89±3.2%. (Panels B, D) 1st derivative plots (integration time
t=2 s), where the △t values evaluated from addition of HbO2 and the full recovery of activity are also shown (details in Materials and methods). T=25 °C.
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[42] the steady state concentration of ATP decreased, by 27%
and 32% in wt and AT cells (Fig. 6A, bottom). As expected, in
the absence of glucose the sensitivity to oligomycin increased in
both cell lines, and the concentration of ATP was decreased by
48% and 70% in wt and AT respectively. This finding suggests
that OXPHOS and glycolysis contribute differently to mito-
chondrial metabolism in AT and wt cells.
The relative contribution of OXPHOS and glycolysis to the
overall ATP production was further evaluated by comparing the
lactate production under standard culture conditions and in the
presence of antimycin and myxothiazole. As shown in Fig. 6B,
OXPHOS ATP was significantly higher in AT than in wt cells,
suggesting that AT cells rely on the oxidative production of ATP
more than controls.
4. Discussion
The results of the experiments herein reported suggest that
upon increasing the electron flux through the respiratory chainthe NO inhibition of CcOX is significantly greater in AT cells
than in controls. As expected, the respiration of both AT and wt
cells was promptly inhibited by μM NO added as a single bolus
[28]. Under basal metabolic conditions the rapid removal of
free NO from both AT and wt cells (e.g. by HbO2) resulted in
the rapid, not time resolved in the O2 electrode, recovery of
respiration [28], attributed to oxidation of NO to nitrite in the
active site [28,29,43]. The stable formation of the nitrosyl
CcOX–NO derivative, was obtained in the presence of excess
ascorbate and TMPD in the dark [28,29]; following inhibition,
and after exhaustion of bulk NO, AT cells recovered activity
with slower kinetics than wt cells. Owing to the presence of
HbO2 trapping any (putative) trace of NO the slow recovery of
respiration cannot be attributed to re-binding to CcOX of free
NO (not detected by the electrode). As also shown previously
[28,29], the slow recovery rather suggests that even in unlimited
O2 (air-equilibrated media) with high electron flux through the
respiratory chain, CcOX in AT cells reacts with NO forming
the more stable CcOX–NO inhibited derivative. This latter
condition is compatible with mitochondrial impairment since
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longer times [28,29]. Based on the ELISA quantification of the
cell cytochrome c content, and the immunoblotting results, we
suggest that the higher O2 consumption rate induced by TMPD
in AT, under otherwise identical conditions of O2 concentration
(270 μM) and mitochondrial mass (virtually identical citrate
synthase activity in the two cell lines) is due to the higher
(∼50%) concentration of cytochrome c detected in AT cells.
This finding is fully consistent with the hypothesis linking
CcOX nitrosylation to the level of electron flux through the
respiratory chain [28–30] providing a feasible molecular ex-
planation for the greater degree of CcOX nitrosylation observed
in AT compared to wt in the presence of ascorbate and TMPD.
Alternative possibilities such as more favoured reaction of
electron donation by cytochrome c at the binding site on CcOX
or intrinsically different reactivity of CcOX towards NO in ATFig. 6. OXPHOS versus glycolytic ATP in wild type and Ataxia Telangiectasia
lymphoblastoid cells. (Panel A) Stationary concentrations of ATP determined in
AT and wt cells, before (solid bars) or after (dotted bars) 1.5 h oligomycin
treatment. Measurements were carried out in the presence (left) or absence
(right) of glucose. Top: Absolute ATP values (⁎P valueb0.05 vs untreated AT
cells, ⁎⁎ P valueb0.001 vs untreated AT and wt cells). Bottom: fractional ATP
changes. (⁎ P valueb0.05 vs wt cells). Values represent the mean±SEM (n=6).
(Panel B) Stationary concentration of lactate in AT and wt cells. Top: lactate
produced in the presence of 1 mM glucose, by cells treated or not with
myxothiazol (M), and antimycin A (A) (OXPHOS inhibitors), 10 μM each. ⁎,
Pb0.05 vs untreated AT cells. Bottom: Difference in lactate (Δlac) was divided
by the basal lactate (no inhibitors) and the value reported as indicative of
the ratio between OXPHOS and glycolytic ATP (details in Materials
and methods). ⁎, Pb0.05 vs wild type cells. Values represent the mean±SEM
(n=6).
Fig. 5. Residual inhibition of cell respiration by NO. (Panel A) Dependence of
inhibition on the concentration of TMPD added to wild type (○) and Ataxia
Telangiectasia (●) cells, 1×107 cells ml–1. Inhibition (%) is defined as [1– (Va/
Vb)]×100 and is reported in y axis. The ratio Va/Vb=1 when residual inhibition=0,
whereas it decreases when inhibition increases (Va/Vbb1). Measurements were
carried out in the presence of excess ascorbate, and in the dark to stabilize the
Fe2+NO adduct of CcOX formed in the presence of 2 μMNO; light fully abolished
the inhibition detectable after removal of free NO by HbO2. Notice that when AT
cells are close to the maximal inhibition predictable wt is inhibited only by 50% of
this value. Data points represent the mean±SEM (n=6–9). ⁎,Pb0.05 vswild type
cells. (Panel B) Extent of inhibition as a function of the rate of O2 consumption by
cytochrome c oxidase. The percentages of residual inhibition are reported for any
cell line as a function of the rate of respiration measured at any given TMPD
concentration before addition of NO (symbols as in panel A). The curve is the
best fit to a hyperbola obtained using Origin 7.0 Global Best Fitting (Northampton,
MA 01060— USA) (details in Materials and methods).cells, cannot be excluded but definitely appear less likely. Under
standard culture conditions, the expected NO concentration in
the cell cytoplasm is in the few 10th of nM range [44,45], and
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nitrite [27,46], particularly under conditions of unlimited O2
supply and basal electron transfer rates [28]. Under these basal
metabolic conditions and production of NO by the constitutive
NOSs, a limited depression of mitochondrial potential has been
reported [24,44], and herein confirmed (not shown). The
evaluation of the ATP and lactate produced by intact cells in
the presence and absence of respiratory chain inhibitors sug-
gests that AT cells rely on oxidative ATP more than wt, sug-
gesting in turn that AT cells may contain a higher fraction of
state 3 mitochondria than wt. This observation further supports
the idea that CcOX in AT cells is more reactive towards NO,
since state 3 mitochondria were reported to be more susceptible
to NO inhibition [29,47,48]. In this respect, however, the
correlation between the extent and type of NO inhibition and the
mitochondrial functional state (state 3 or state 4) of intact AT
and wt cells needs to be directly assessed.
The mitochondrial response to NO particularly at the CcOX
level has been proposed to be part of the cell signalling
pathways [49], so that the ability for a cell line to efficiently
control the mitochondrial NO concentration and traffic appears
an important property for cell survival. The CcOX and NO
chemistry might become particularly relevant under all condi-
tions of increased half life of NO, particularly when O2 supply is
diminished [30] and eNOS is activated [50], and/or during
infections (iNOS activation), with massive NO release. Based
on our results, it is tempting to speculate that under similar
conditions of electron flux rates (high) and O2 availability (low),
also in vivo the respiratory chain of AT cells exposed to NO will
be more nitrosylated, i.e. more inhibited, than that of the wt
cells. If confirmed, this finding would imply that lymphocytes
of AT patients exposed to pulses of NO, for example in hypoxic
infected sites (tissues, organs), would be able to synthesize
OXPHOS ATP to a lower level than normal lymphocytes. One
might speculate that the immunodeficiency characteristic of the
AT patients can be attributed, at least to some extent, to severe
NO inhibition impairing the mitochondrial bioenergetics of
their lymphoid cells. According to our results, the availability in
the cell of cytochrome c at the CcOX site controls type and
extent of mitochondrial NO inhibition. It is tempting to specu-
late, whether the control of the cytochrome c expression may
form the basis of a possible therapeutic intervention in this and
similar pathologies.
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